QA: Comera Life Sciences Holdings Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001907685_2023_Comera_Life_Sciences_Holdings_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001907685, Comera Life Sciences Holdings Inc

  xvar xval
0 AssetsCurrent 3,063,098
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 257,186
3 remainder_Assets 406,829
4 LiabilitiesCurrent 5,058,682
5 LiabilitiesNoncurrent 120,302
6 remainder_Liabilities 277,507
7 CostOfGoodsAndServicesSold 210,390
8 SellingGeneralAndAdministrativeExpense 10,652,894
9 ResearchAndDevelopmentExpense 1,739,833
10 remainder_Expenses 0
11 remainder_Revenues 633,102
12 remainder_NetIncome -6,034,083
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 3,727,113
1 Liabilities 5,456,491
2 Expenses 12,603,117
3 Revenues 633,102
4 StockholdersEquity -1,729,378
5 NetIncome -18,004,098
6 ComprehensiveNetIncome -18,004,098
7 BaseVar 14,226,953
8 EconomicCapitalRatiobeforeLimitedLiability -4.74
9 EconomicCapitalRatio 0.233

Edgar->Model Mapping

Feature Distribution